Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps

被引:0
作者
Toppila-Salmi, Sanna [1 ,2 ,3 ,4 ]
Lyly, Annina [5 ,6 ]
Simin, Johanna [7 ]
Aakko, Juhani [7 ]
Olsen, Helga Haugom [5 ]
Lehtimaki, Lauri [8 ,9 ]
机构
[1] Univ Eastern Finland, Dept Otorhinolaryngol, Kuopio, Finland
[2] Wellbeing Serv Cty Pohjois Savo, Dept Otorhinolaryngol, Kuopio, Finland
[3] Helsinki Univ Hosp, Inflammat Ctr, Dept Allergol, Helsinki, Finland
[4] Univ Helsinki, Helsinki, Finland
[5] AstraZeneca Nordics, Med Affairs, Espoo, Finland
[6] AstraZeneca Nordics, Med & Regulatory, Oslo, Norway
[7] Medaffcon Oy, Espoo, Finland
[8] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[9] Tampere Univ Hosp, Allergy Ctr, Tampere, Finland
关键词
chronic rhinosinusitis; CRSwNP; endoscopic surgery; nasal polyps; revision surgery; PREVALENCE; GUIDELINES; OUTCOMES; ASTHMA;
D O I
10.1002/clt2.70032
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Although patients with chronic rhinosinusitis with nasal polyps (CRSwNP) may benefit from endoscopic sinus surgery (ESS), some patients will experience polyp recurrence, adding to the overall disease burden of CRSwNP. We aimed to investigate predictors of revision ESS in patients with CRSwNP. Methods A nationwide population-based study including all adults diagnosed with CRSwNP who had surgical procedure codes for ESS (N = 3506), followed up between January 2012 and December 2019. Logistic regression models provided adjusted odds ratios (OR) with 95% confidence intervals (CIs) for the odds of revision surgery within one and 3 years post-index surgery. Results 559 (15.9%) of the patients had at least one revision surgery during the follow-up. Median time to revision of ESS was 425 days (interquartile range: 213-898). Baseline asthma (OR = 1.58, 95% CI 1.17-2.12) and antibiotic use (OR = 1.61, 95% CI 1.27-2.04) were associated with higher odds of revision ESS, particularly within 3 years post-index surgery, whereas Increasing age was inversely associated with the odds of ESS revision (OR = 0.82, 95% CI 0.76-0.88). The highest odds of revision ESS were observed within 3 years post-index surgery in patients who had undergone extensive surgery at index (OR = 14.13, 95% CI 3.41-95.64) compared with those who had undergone limited surgery. OCS use was frequent among CRSwNP patients, with a higher cumulative dose in patients undergoing multiple ESS revisions (63%, n = 97, median daily dose 3.29 mg, IQR: 1.64-3.70) compared with patients without revisions (49%, n = 1361 and 1.64 mg, IQR: 1.64-3.29, respectively. p-value <0.001). Conclusions A small proportion of CRSwNP patients require revision ESS with associated high cumulative OCS doses, highlighting the need for additional therapies to achieve disease control and reduce the corticosteroid burden. A few simple baseline characteristics can predict the need for recurrent surgery among the patients with CRSwNP.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Evidence-based Surgery for Chronic Rhinosinusitis with and without Nasal Polyps
    Georgalas, Christos
    Cornet, Marjolein
    Adriaensen, Gwijde
    Reinartz, Susanne
    Holland, Carlijn
    Prokopakis, Emmanuel
    Fokkens, Wytske
    CURRENT ALLERGY AND ASTHMA REPORTS, 2014, 14 (04)
  • [42] Anatomical findings in patients with chronic rhinosinusitis without nasal polyps requiring revision surgery
    Englhard, Anna Sophie
    Ledderose, Georg Johannes
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2023, 89 (04)
  • [43] Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps
    Hopkins, Claire
    Wagenmann, Martin
    Bachert, Claus
    Desrosiers, Martin
    Han, Joseph K.
    Hellings, Peter W.
    Lee, Stella E.
    Msihid, Jerome
    Radwan, Amr
    Rowe, Paul
    Amin, Nikhil
    Deniz, Yamo
    Ortiz, Benjamin
    Mannent, Leda P.
    Rout, Rajesh
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (07) : 1087 - 1101
  • [44] Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype
    Miglani, Amar
    Divekar, Rohit D.
    Azar, Antoine
    Rank, Matthew A.
    Lal, Devyani
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (09) : 1047 - 1051
  • [45] Chronic rhinosinusitis with nasal polyps: predictors of recurrence 5 years after surgery
    Gomes, Pedro Marques
    Cabral, Diogo Cunha
    Barreto, Joana
    Carcao, Andre Alves
    Duarte, Delfim
    Peneda, Jose Ferreira
    ACTA OTO-LARYNGOLOGICA, 2024, 144 (11-12) : 635 - 640
  • [46] Biologics versus functional endoscopic sinus surgery for the treatment of chronic rhinosinusitis with nasal polyps: a literature review
    Alshatti, Asmaa
    Webb, Christopher
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2024, 138 (04) : 361 - 366
  • [47] Presurgical olfactory function as an indicator of the outcome of functional endoscopic sinus surgery in chronic rhinosinusitis with nasal polyps
    Constantin A. Hintschich
    Jürgen Pade
    Petros Petridis
    Thomas Hummel
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 5727 - 5733
  • [48] Tobacco Use Increases the Adjusted Risk of Revision Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis
    Gill, Amarbir S.
    Meeks, Huong
    Curtin, Karen
    Alt, Jeremiah A.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2022, 36 (06) : 727 - 732
  • [49] Presurgical olfactory function as an indicator of the outcome of functional endoscopic sinus surgery in chronic rhinosinusitis with nasal polyps
    Hintschich, Constantin A.
    Pade, Juergen
    Petridis, Petros
    Hummel, Thomas
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (12) : 5727 - 5733
  • [50] Endoscopic sinus surgery outcomes in patients with chronic rhinosinusitis and immunoglobulin deficiencies
    Shireen Samargandy
    Elysia Grose
    Jonathan Yip
    John M. Lee
    Journal of Otolaryngology - Head & Neck Surgery, 52